• LAST PRICE
    5.8900
  • TODAY'S CHANGE (%)
    Trending Up0.0800 (1.3769%)
  • Bid / Lots
    4.5100/ 1
  • Ask / Lots
    6.0400/ 1
  • Open / Previous Close
    5.8300 / 5.8100
  • Day Range
    Low 5.8300
    High 5.9489
  • 52 Week Range
    Low 4.6000
    High 6.5291
  • Volume
    16,218
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Wednesday's close: 5.81
TimeVolumeKMDA
09:32 ET4555.8301
09:37 ET29135.87
10:09 ET10005.86
10:11 ET2005.88
10:15 ET1005.88
10:20 ET15005.88
10:24 ET7005.89
10:27 ET4005.8993
10:33 ET10005.89
10:40 ET3005.89
10:42 ET2745.89
10:49 ET2005.89
11:00 ET1005.89
11:16 ET23005.89
11:21 ET2925.88
11:39 ET5005.8802
11:45 ET1005.89
12:01 ET3005.88
12:10 ET3005.89
12:21 ET3245.895
12:26 ET7395.895
12:48 ET3005.9
12:51 ET8085.89
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesKMDA
Kamada Ltd
334.0M
19.0x
-22.48%
United StatesSTRO
Sutro Biopharma Inc
221.8M
-1.6x
---
United StatesKPTI
Karyopharm Therapeutics Inc
109.8M
-1.1x
---
United StatesHRTX
Heron Therapeutics Inc
176.4M
-6.5x
---
United StatesMCRB
Seres Therapeutics Inc
149.7M
-0.9x
---
United StatesARCT
Arcturus Therapeutics Holdings Inc
474.3M
-7.9x
---
As of 2024-12-01

Company Information

Kamada Ltd is Israel based company, focused on plasma-derived protein therapeutics with a commercial product portfolio and a late-stage product pipeline. The Company uses its proprietary platform technology and know-how for the extraction and purification of proteins from human plasma to produce Alpha-1 Antitrypsin (AAT) in a highly-purified, liquid form, as well as other plasma-derived Immune globulins.

Contact Information

Headquarters
2 Holtzman St., Science ParkREHOVOT, Israel 7670402
Phone
---
Fax
---

Executives

Chairman of the Board
Lilach Asher Topilsky
Chief Executive Officer
Amir London
Deputy Chairman of the Board
David Tsur
Chief Financial Officer
Chaime Orlev
Senior Vice President - Scientific Affairs
Ruth Wolfson

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$334.0M
Revenue (TTM)
$158.4M
Shares Outstanding
57.5M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
0.99
EPS
$0.31
Book Value
$4.25
P/E Ratio
19.0x
Price/Sales (TTM)
2.1
Price/Cash Flow (TTM)
11.7x
Operating Margin
11.21%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.